Table 4.
Prognostic models of the change in continuous mMRI small bowel motility score and change in fecal calprotectin to predict improved quality of life.
| Quality of Life measure | N | mMRI (95% CI) |
P-value | AIC | FC (95% CI) |
P-value | AIC |
| EQ-5D-5L | 42 | 0.0002 (−0.0004, 0.0007) |
.54 | −31.7 | 0.0001 (−0.0001, 0.0003) |
.20 | −33.3 |
| CUCQ-8 | 41 | −0.04 (−0.05, 0.04) |
.87 | 340.6 | −0.02 (−0.37, −0.001) |
.04 | 335.3 |
| IBD-Control 8 | 36 | 0.00002 (−0.02, 0.02) |
.99 | 215.5 | −0.01 (−0.13, −0.003) |
.00 | 204.8 |
Abbreviations: AIC = Aikake Information Criterion; smaller values indicate a better model fit; CUCQ-8 = Crohn’s and Ulcerative Colitis Questionnaire 8 item; EQ-5D-5L = European Quality of Life 5 dimension, 5 level; IBD-Control = Inflammatory Bowel Disease Control.
Modeling was conducted without adjustment for covariates due to the small number of events.